Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Sonntag, 12.02.2012Börsentäglich über 11.000 News von 420 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

MEDA

WKN: 935166  ISIN: SE0000221723  Ticker-Symbol: M5E 
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDA Chart 1 Jahr
1-Woche-Intraday-Chart
MEDA 1-Woche-Intraday-Chart

Aktuelle News zur MEDA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
23.01. 2
23.01. 60
ALLEGAN, Mich., Jan. 23, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug...
Mehr lesen zu:
Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals
29.12. 54
JEFFERSON CITY, MO -- (Marketwire) -- 12/29/11 -- Today the Missouri Energy Development Association (MEDA) announced it will propose renewable energy legislation during the next session of the Missouri...
Mehr lesen zu:
MEDA Announces Legislation on Renewable Energy / Says Renew Missouri Petition Would Result in Excessive Rate Increases on Missourians
15.12. 54
Regulatory News: FDA, the U.S. Food and Drug Administration, has informed Meda (STO:MEDAA) that the PDUFA (Prescription Drug User Fee Act) date for ...
Mehr lesen zu:
Meda Announces PDUFA Timeline for Dymista
09.12. 56
Regulatory News: Meda (STO:MEDAA) has signed a 5-year collaboration agreement with Omega Pharma for SB12 in France, Italy, Belgium and Greece. Omega Pharma...
Mehr lesen zu:
MEDA: Collaboration with Omega Pharma for SB12
06.12. 36
Regulatory News: The United States Patent and Trademark Office (USPTO) today issued a patent related to Astepro (azelastine) nasal spray. This patent will...
Mehr lesen zu:
MEDA: Astepro patent granted
30.11. 30
Regulatory News: Moberg Derma AB (publ.)(STO:MOB) and Meda have entered into an additional license agreement for Nalox™ - Moberg Derma's patented product...
Mehr lesen zu:
Moberg Derma AB: Moberg Derma and Meda Extend License Agreement
17.11. 35
Regulatory News: Meda (STO:MEDAA) has agreed to acquire three well-established Nordic OTC drugs from McNeil AB/Cilag GmbH International, members of the Johnson...
Mehr lesen zu:
Meda Acquires Treo
02.11. 49
Regulatory News: Meda AB (STO:MEDAA): · Group net sales reached SEK 9,400 million (8,561). At fixed currency rates, sales increased 19%. ...
Mehr lesen zu:
Meda AB (publ) – Interim report, January-September 2011
28.10. 39
Regulatory News: The marketing authorization application for Dymista (a novel formulation of azelastine hydrochloride and fluticasone propionate) has been...
Mehr lesen zu:
MEDA: Dymista Filed in Europe
21.10. 41
Regulatory News: As per specifications set at Meda's 2011 annual general meeting, a nomination committee has been appointed. It consists of: ...
Mehr lesen zu:
MEDA: Nomination Committee Appointed
19.09. 72
Regulatory News: Moberg Derma AB (STO:MOB)(OMX: MOB) and Meda AB have entered into a license agreement covering rights for Nalox® - Moberg Derma's patented...
Mehr lesen zu:
Moberg Derma AB: Moberg Derma and Meda Sign Agreement for Nalox in Europe
19.09. 51
Regulatory News: Meda (STO:MEDAA) has acquired exclusive licensing rights to Nalox (treatment of fungal nail infections/nail psoriasis) from Moberg Derma ...
Mehr lesen zu:
Meda Acquires Rights to Nalox in Europe
13 Nachrichten in den letzten 6 Monaten